Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: An implication for boosting

Vaccine

Volumn 25, Issue 51, 2007, Pages 8508-8511

  Lin, Ching Chiang ^a,b,c   Chang, Chen Kang ^d   Huang, Yeou Lih ^c,e   Tseng, Hung Fu ^f  

^a FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY OF SPORT   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B virus; Seroprevalence; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEPATITIS B; HUMAN; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NORMAL HUMAN; NURSING STUDENT; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TAIWAN; VACCINATION;

ADOLESCENT; ADULT; FEMALE; HEALTH PLANNING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOENZYME TECHNIQUES; MALE; NURSING; SEROEPIDEMIOLOGIC STUDIES; STUDENTS; TAIWAN;

EID: 36549026862     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.018     Document Type: Article

References (29)

1. Chen D.S., Hsu N.H., Sung J.L., Hsu T.C., Hsu S.T., Kuo Y.T., et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257 (1987) 2597-2603
2. Chien Y.C., Jan C.F., Kuo H.S., and Chen C.J. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 28 (2006) 126-135
3. Chang M.H., Shau W.Y., Chen C.J., Wu T.C., Kong M.S., Liang D.C., et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 284 (2000) 3040-3042
4. Lee C.Y., Huang L.M., Chang M.H., Hsu C.Y., Wu S.J., Sung J.L., et al. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J 10 (1991) 299-303
5. Stevens C.E., Toy P.T., Taylor P.E., Lee T., and Yip H.Y. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 90 (1992) 170-173
6. Lee P.I., Lee C.Y., Huang L.M., and Chang M.H. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr 126 (1995) 716-721
7. Coursaget P., Leboulleux D., Soumare M., Le Cann P., Yvonnet B., Chiron J.P., et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 21 (1994) 250-254
8. Resti M., Azzari C., Mannelli F., Rossi M.E., Lionetti P., and Vierucci A. Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?. Vaccine 15 (1997) 1338-1340
9. Huang L.M., Chiang B.L., Lee C.Y., Lee P.I., Chi W.K., and Chang M.H. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 29 (1999) 954-959
10. Wang R.X., Guo Y., Yang C.H., Song Y., Chen J., Pang F.S., et al. Can HB vaccine yield a booster effect on individuals with positive serum anti-HBs and anti-HBc markers?. World J Gastroenterol 10 (2004) 306-308
11. Lu C.Y., Chiang B.L., Chi W.K., Chang M.H., Ni Y.H., Hsu H.M., et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 40 (2004) 1415-1420
12. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;355:561-65.
13. Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep 1991;40:1-25.
14. Holton D. Revised guidelines for booster vaccination against hepatitis B. Can Med Assoc J 147 (1992) 1029-1032
15. Thompson S.C., and Norris M. Hepatitis B vaccination of personnel employed in Victorian hospitals: are those at risk adequately protected?. Infect Control Hosp Epidemiol 20 (1999) 51-54
16. Barash C., Conn M.I., DiMarino Jr. A.J., Marzano J., and Allen M.L. Serologic hepatitis B immunity in vaccinated health care workers. Arch Intern Med 159 (1999) 1481-1483
17. Davies G.R., and Porra M. The need for post-vaccination serology and the timing of booster vaccinations against hepatitis B in dental health care workers. Aust Dent J 39 (1994) 238-241
18. Shiao J., Guo L., and McLaws M.L. Estimation of the risk of bloodborne pathogens to health care workers after a needlestick injury in Taiwan. Am J Infect Control 30 (2002) 15-20
19. Hsu H.M., Lu C.F., Lee S.C., Lin S.R., and Chen D.S. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 179 (1999) 367-370
20. Lu S.N., Chen C.H., Chen T.M., Lee P.L., Wang J.H., Tung H.D., et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24 (2006) 759-765
21. Lin H.H., Wang L.Y., Hu C.T., Huang S.C., Huang L.C., Lin S.S., et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 69 (2003) 471-474
22. Alter H.J., Seeff L.B., Kaplan P.M., McAuliffe V.J., Wright E.C., Gerin J.L., et al. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 295 (1976) 909-913
23. Werner B.G., and Grady G.F. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med 97 (1982) 367-369
24. Karayiannis P., Novick D.M., Lok A.S., Fowler M.J., Monjardino J., and Thomas H.C. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J 290 (1985) 1853-1855
25. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276 (1996) 906-908
26. John T.J., and Cooksley G. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?. J Gastroenterol Hepatol 20 (2005) 5-10
27. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B. Can Commun Dis Rep 1992;18:121-22.
28. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 132 (2007) 1287-1293
29. Gerberding J.L. Management of occupational exposures to blood-borne viruses. N Engl J Med 332 (1995) 444-451